nodes	percent_of_prediction	percent_of_DWPC	metapath
Terconazole—Toxic epidermal necrolysis—Chlorambucil—testicular cancer	0.0179	0.0179	CcSEcCtD
Terconazole—Pain—Carboplatin—testicular cancer	0.0163	0.0163	CcSEcCtD
Terconazole—Body temperature increased—Carboplatin—testicular cancer	0.015	0.015	CcSEcCtD
Terconazole—Bronchospasm—Bleomycin—testicular cancer	0.0131	0.0131	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Dactinomycin—testicular cancer	0.0129	0.0129	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Ifosfamide—testicular cancer	0.0119	0.0119	CcSEcCtD
Terconazole—Bronchospasm—Ifosfamide—testicular cancer	0.0112	0.0112	CcSEcCtD
Terconazole—Face oedema—Cisplatin—testicular cancer	0.011	0.011	CcSEcCtD
Terconazole—Ill-defined disorder—Vinblastine—testicular cancer	0.0102	0.0102	CcSEcCtD
Terconazole—Malaise—Vinblastine—testicular cancer	0.00991	0.00991	CcSEcCtD
Terconazole—Chills—Bleomycin—testicular cancer	0.00956	0.00956	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Etoposide—testicular cancer	0.00936	0.00936	CcSEcCtD
Terconazole—Discomfort—Vinblastine—testicular cancer	0.00924	0.00924	CcSEcCtD
Terconazole—Chills—Dactinomycin—testicular cancer	0.00892	0.00892	CcSEcCtD
Terconazole—Bronchospasm—Etoposide—testicular cancer	0.00884	0.00884	CcSEcCtD
Terconazole—Ill-defined disorder—Bleomycin—testicular cancer	0.00861	0.00861	CcSEcCtD
Terconazole—Malaise—Bleomycin—testicular cancer	0.00837	0.00837	CcSEcCtD
Terconazole—Pain—Chlorambucil—testicular cancer	0.00837	0.00837	CcSEcCtD
Terconazole—Chills—Ifosfamide—testicular cancer	0.00817	0.00817	CcSEcCtD
Terconazole—Feeling abnormal—Chlorambucil—testicular cancer	0.00806	0.00806	CcSEcCtD
Terconazole—Ill-defined disorder—Dactinomycin—testicular cancer	0.00803	0.00803	CcSEcCtD
Terconazole—Gastrointestinal pain—Chlorambucil—testicular cancer	0.008	0.008	CcSEcCtD
Terconazole—Myalgia—Bleomycin—testicular cancer	0.0079	0.0079	CcSEcCtD
Terconazole—Discomfort—Bleomycin—testicular cancer	0.0078	0.0078	CcSEcCtD
Terconazole—Malaise—Dactinomycin—testicular cancer	0.0078	0.0078	CcSEcCtD
Terconazole—Influenza like illness—Epirubicin—testicular cancer	0.0078	0.0078	CcSEcCtD
Terconazole—Urticaria—Chlorambucil—testicular cancer	0.00777	0.00777	CcSEcCtD
Terconazole—Abdominal pain—Chlorambucil—testicular cancer	0.00773	0.00773	CcSEcCtD
Terconazole—Body temperature increased—Chlorambucil—testicular cancer	0.00773	0.00773	CcSEcCtD
Terconazole—Pain—Vinblastine—testicular cancer	0.00767	0.00767	CcSEcCtD
Terconazole—Anaphylactic shock—Bleomycin—testicular cancer	0.00757	0.00757	CcSEcCtD
Terconazole—Feeling abnormal—Vinblastine—testicular cancer	0.00739	0.00739	CcSEcCtD
Terconazole—Myalgia—Dactinomycin—testicular cancer	0.00737	0.00737	CcSEcCtD
Terconazole—Ill-defined disorder—Ifosfamide—testicular cancer	0.00736	0.00736	CcSEcCtD
Terconazole—Gastrointestinal pain—Vinblastine—testicular cancer	0.00733	0.00733	CcSEcCtD
Terconazole—Discomfort—Dactinomycin—testicular cancer	0.00728	0.00728	CcSEcCtD
Terconazole—Influenza like illness—Doxorubicin—testicular cancer	0.00722	0.00722	CcSEcCtD
Terconazole—Hypersensitivity—Chlorambucil—testicular cancer	0.00721	0.00721	CcSEcCtD
Terconazole—Malaise—Ifosfamide—testicular cancer	0.00715	0.00715	CcSEcCtD
Terconazole—Abdominal pain—Vinblastine—testicular cancer	0.00709	0.00709	CcSEcCtD
Terconazole—Asthenia—Chlorambucil—testicular cancer	0.00702	0.00702	CcSEcCtD
Terconazole—Pruritus—Chlorambucil—testicular cancer	0.00692	0.00692	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.0069	0.0069	CcSEcCtD
Terconazole—Myalgia—Ifosfamide—testicular cancer	0.00675	0.00675	CcSEcCtD
Terconazole—Arthralgia—Ifosfamide—testicular cancer	0.00675	0.00675	CcSEcCtD
Terconazole—Discomfort—Ifosfamide—testicular cancer	0.00667	0.00667	CcSEcCtD
Terconazole—Hypersensitivity—Vinblastine—testicular cancer	0.0066	0.0066	CcSEcCtD
Terconazole—Pain—Bleomycin—testicular cancer	0.00647	0.00647	CcSEcCtD
Terconazole—Anaphylactic shock—Ifosfamide—testicular cancer	0.00647	0.00647	CcSEcCtD
Terconazole—Chills—Etoposide—testicular cancer	0.00645	0.00645	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00643	0.00643	CcSEcCtD
Terconazole—Asthenia—Vinblastine—testicular cancer	0.00643	0.00643	CcSEcCtD
Terconazole—Ill-defined disorder—Cisplatin—testicular cancer	0.00634	0.00634	CcSEcCtD
Terconazole—Feeling abnormal—Bleomycin—testicular cancer	0.00624	0.00624	CcSEcCtD
Terconazole—Vomiting—Chlorambucil—testicular cancer	0.00622	0.00622	CcSEcCtD
Terconazole—Malaise—Cisplatin—testicular cancer	0.00616	0.00616	CcSEcCtD
Terconazole—Pain—Dactinomycin—testicular cancer	0.00604	0.00604	CcSEcCtD
Terconazole—Urticaria—Bleomycin—testicular cancer	0.00601	0.00601	CcSEcCtD
Terconazole—Body temperature increased—Bleomycin—testicular cancer	0.00599	0.00599	CcSEcCtD
Terconazole—Dizziness—Vinblastine—testicular cancer	0.00593	0.00593	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.0059	0.0059	CcSEcCtD
Terconazole—Myalgia—Cisplatin—testicular cancer	0.00582	0.00582	CcSEcCtD
Terconazole—Feeling abnormal—Dactinomycin—testicular cancer	0.00582	0.00582	CcSEcCtD
Terconazole—Nausea—Chlorambucil—testicular cancer	0.00581	0.00581	CcSEcCtD
Terconazole—Ill-defined disorder—Etoposide—testicular cancer	0.00581	0.00581	CcSEcCtD
Terconazole—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00577	0.00577	CcSEcCtD
Terconazole—Discomfort—Cisplatin—testicular cancer	0.00575	0.00575	CcSEcCtD
Terconazole—Vomiting—Vinblastine—testicular cancer	0.0057	0.0057	CcSEcCtD
Terconazole—Malaise—Etoposide—testicular cancer	0.00565	0.00565	CcSEcCtD
Terconazole—Face oedema—Epirubicin—testicular cancer	0.00563	0.00563	CcSEcCtD
Terconazole—Headache—Vinblastine—testicular cancer	0.00562	0.00562	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.00561	0.00561	CcSEcCtD
Terconazole—Abdominal pain—Dactinomycin—testicular cancer	0.00558	0.00558	CcSEcCtD
Terconazole—Body temperature increased—Dactinomycin—testicular cancer	0.00558	0.00558	CcSEcCtD
Terconazole—Anaphylactic shock—Cisplatin—testicular cancer	0.00558	0.00558	CcSEcCtD
Terconazole—Hypersensitivity—Bleomycin—testicular cancer	0.00558	0.00558	CcSEcCtD
Terconazole—Pain—Ifosfamide—testicular cancer	0.00553	0.00553	CcSEcCtD
Terconazole—Asthenia—Bleomycin—testicular cancer	0.00543	0.00543	CcSEcCtD
Terconazole—Pruritus—Bleomycin—testicular cancer	0.00536	0.00536	CcSEcCtD
Terconazole—Feeling abnormal—Ifosfamide—testicular cancer	0.00533	0.00533	CcSEcCtD
Terconazole—Nausea—Vinblastine—testicular cancer	0.00532	0.00532	CcSEcCtD
Terconazole—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00529	0.00529	CcSEcCtD
Terconazole—Discomfort—Etoposide—testicular cancer	0.00527	0.00527	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00525	0.00525	CcSEcCtD
Terconazole—Face oedema—Doxorubicin—testicular cancer	0.00521	0.00521	CcSEcCtD
Terconazole—Hypersensitivity—Dactinomycin—testicular cancer	0.0052	0.0052	CcSEcCtD
Terconazole—Urticaria—Ifosfamide—testicular cancer	0.00514	0.00514	CcSEcCtD
Terconazole—Abdominal pain—Ifosfamide—testicular cancer	0.00512	0.00512	CcSEcCtD
Terconazole—Body temperature increased—Ifosfamide—testicular cancer	0.00512	0.00512	CcSEcCtD
Terconazole—Anaphylactic shock—Etoposide—testicular cancer	0.00511	0.00511	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00508	0.00508	CcSEcCtD
Terconazole—Asthenia—Dactinomycin—testicular cancer	0.00507	0.00507	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.00486	0.00486	CcSEcCtD
Terconazole—Vomiting—Bleomycin—testicular cancer	0.00481	0.00481	CcSEcCtD
Terconazole—Rash—Bleomycin—testicular cancer	0.00477	0.00477	CcSEcCtD
Terconazole—Pain—Cisplatin—testicular cancer	0.00477	0.00477	CcSEcCtD
Terconazole—Dermatitis—Bleomycin—testicular cancer	0.00477	0.00477	CcSEcCtD
Terconazole—Hypersensitivity—Ifosfamide—testicular cancer	0.00477	0.00477	CcSEcCtD
Terconazole—Asthenia—Ifosfamide—testicular cancer	0.00464	0.00464	CcSEcCtD
Terconazole—Feeling abnormal—Cisplatin—testicular cancer	0.0046	0.0046	CcSEcCtD
Terconazole—Pruritus—Ifosfamide—testicular cancer	0.00458	0.00458	CcSEcCtD
Terconazole—Nausea—Bleomycin—testicular cancer	0.0045	0.0045	CcSEcCtD
Terconazole—Vomiting—Dactinomycin—testicular cancer	0.00449	0.00449	CcSEcCtD
Terconazole—Rash—Dactinomycin—testicular cancer	0.00445	0.00445	CcSEcCtD
Terconazole—Body temperature increased—Cisplatin—testicular cancer	0.00441	0.00441	CcSEcCtD
Terconazole—Pain—Etoposide—testicular cancer	0.00437	0.00437	CcSEcCtD
Terconazole—Dizziness—Ifosfamide—testicular cancer	0.00428	0.00428	CcSEcCtD
Terconazole—Feeling abnormal—Etoposide—testicular cancer	0.00421	0.00421	CcSEcCtD
Terconazole—Nausea—Dactinomycin—testicular cancer	0.00419	0.00419	CcSEcCtD
Terconazole—Gastrointestinal pain—Etoposide—testicular cancer	0.00418	0.00418	CcSEcCtD
Terconazole—Vomiting—Ifosfamide—testicular cancer	0.00411	0.00411	CcSEcCtD
Terconazole—Hypersensitivity—Cisplatin—testicular cancer	0.00411	0.00411	CcSEcCtD
Terconazole—Rash—Ifosfamide—testicular cancer	0.00408	0.00408	CcSEcCtD
Terconazole—Dermatitis—Ifosfamide—testicular cancer	0.00408	0.00408	CcSEcCtD
Terconazole—Urticaria—Etoposide—testicular cancer	0.00406	0.00406	CcSEcCtD
Terconazole—Abdominal pain—Etoposide—testicular cancer	0.00404	0.00404	CcSEcCtD
Terconazole—Body temperature increased—Etoposide—testicular cancer	0.00404	0.00404	CcSEcCtD
Terconazole—Asthenia—Cisplatin—testicular cancer	0.004	0.004	CcSEcCtD
Terconazole—Chills—Methotrexate—testicular cancer	0.00387	0.00387	CcSEcCtD
Terconazole—Nausea—Ifosfamide—testicular cancer	0.00384	0.00384	CcSEcCtD
Terconazole—Hypersensitivity—Etoposide—testicular cancer	0.00377	0.00377	CcSEcCtD
Terconazole—Asthenia—Etoposide—testicular cancer	0.00367	0.00367	CcSEcCtD
Terconazole—Chills—Epirubicin—testicular cancer	0.00362	0.00362	CcSEcCtD
Terconazole—Pruritus—Etoposide—testicular cancer	0.00362	0.00362	CcSEcCtD
Terconazole—Vomiting—Cisplatin—testicular cancer	0.00355	0.00355	CcSEcCtD
Terconazole—Rash—Cisplatin—testicular cancer	0.00352	0.00352	CcSEcCtD
Terconazole—Dermatitis—Cisplatin—testicular cancer	0.00351	0.00351	CcSEcCtD
Terconazole—Ill-defined disorder—Methotrexate—testicular cancer	0.00348	0.00348	CcSEcCtD
Terconazole—Malaise—Methotrexate—testicular cancer	0.00338	0.00338	CcSEcCtD
Terconazole—Dizziness—Etoposide—testicular cancer	0.00338	0.00338	CcSEcCtD
Terconazole—Chills—Doxorubicin—testicular cancer	0.00335	0.00335	CcSEcCtD
Terconazole—Nausea—Cisplatin—testicular cancer	0.00331	0.00331	CcSEcCtD
Terconazole—Ill-defined disorder—Epirubicin—testicular cancer	0.00326	0.00326	CcSEcCtD
Terconazole—Vomiting—Etoposide—testicular cancer	0.00325	0.00325	CcSEcCtD
Terconazole—Rash—Etoposide—testicular cancer	0.00322	0.00322	CcSEcCtD
Terconazole—Dermatitis—Etoposide—testicular cancer	0.00322	0.00322	CcSEcCtD
Terconazole—Headache—Etoposide—testicular cancer	0.0032	0.0032	CcSEcCtD
Terconazole—Myalgia—Methotrexate—testicular cancer	0.00319	0.00319	CcSEcCtD
Terconazole—Arthralgia—Methotrexate—testicular cancer	0.00319	0.00319	CcSEcCtD
Terconazole—Malaise—Epirubicin—testicular cancer	0.00317	0.00317	CcSEcCtD
Terconazole—Discomfort—Methotrexate—testicular cancer	0.00315	0.00315	CcSEcCtD
Terconazole—Anaphylactic shock—Methotrexate—testicular cancer	0.00306	0.00306	CcSEcCtD
Terconazole—Nausea—Etoposide—testicular cancer	0.00304	0.00304	CcSEcCtD
Terconazole—Ill-defined disorder—Doxorubicin—testicular cancer	0.00301	0.00301	CcSEcCtD
Terconazole—Myalgia—Epirubicin—testicular cancer	0.00299	0.00299	CcSEcCtD
Terconazole—Arthralgia—Epirubicin—testicular cancer	0.00299	0.00299	CcSEcCtD
Terconazole—Discomfort—Epirubicin—testicular cancer	0.00295	0.00295	CcSEcCtD
Terconazole—Malaise—Doxorubicin—testicular cancer	0.00293	0.00293	CcSEcCtD
Terconazole—Anaphylactic shock—Epirubicin—testicular cancer	0.00286	0.00286	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00279	0.00279	CcSEcCtD
Terconazole—Myalgia—Doxorubicin—testicular cancer	0.00277	0.00277	CcSEcCtD
Terconazole—Arthralgia—Doxorubicin—testicular cancer	0.00277	0.00277	CcSEcCtD
Terconazole—Discomfort—Doxorubicin—testicular cancer	0.00273	0.00273	CcSEcCtD
Terconazole—Anaphylactic shock—Doxorubicin—testicular cancer	0.00265	0.00265	CcSEcCtD
Terconazole—Pain—Methotrexate—testicular cancer	0.00262	0.00262	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00261	0.00261	CcSEcCtD
Terconazole—Feeling abnormal—Methotrexate—testicular cancer	0.00252	0.00252	CcSEcCtD
Terconazole—Gastrointestinal pain—Methotrexate—testicular cancer	0.0025	0.0025	CcSEcCtD
Terconazole—Pain—Epirubicin—testicular cancer	0.00245	0.00245	CcSEcCtD
Terconazole—Urticaria—Methotrexate—testicular cancer	0.00243	0.00243	CcSEcCtD
Terconazole—Body temperature increased—Methotrexate—testicular cancer	0.00242	0.00242	CcSEcCtD
Terconazole—Abdominal pain—Methotrexate—testicular cancer	0.00242	0.00242	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00241	0.00241	CcSEcCtD
Terconazole—Feeling abnormal—Epirubicin—testicular cancer	0.00236	0.00236	CcSEcCtD
Terconazole—Gastrointestinal pain—Epirubicin—testicular cancer	0.00234	0.00234	CcSEcCtD
Terconazole—Urticaria—Epirubicin—testicular cancer	0.00228	0.00228	CcSEcCtD
Terconazole—Pain—Doxorubicin—testicular cancer	0.00227	0.00227	CcSEcCtD
Terconazole—Abdominal pain—Epirubicin—testicular cancer	0.00226	0.00226	CcSEcCtD
Terconazole—Body temperature increased—Epirubicin—testicular cancer	0.00226	0.00226	CcSEcCtD
Terconazole—Hypersensitivity—Methotrexate—testicular cancer	0.00226	0.00226	CcSEcCtD
Terconazole—Asthenia—Methotrexate—testicular cancer	0.0022	0.0022	CcSEcCtD
Terconazole—Feeling abnormal—Doxorubicin—testicular cancer	0.00218	0.00218	CcSEcCtD
Terconazole—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00217	0.00217	CcSEcCtD
Terconazole—Pruritus—Methotrexate—testicular cancer	0.00217	0.00217	CcSEcCtD
Terconazole—Hypersensitivity—Epirubicin—testicular cancer	0.00211	0.00211	CcSEcCtD
Terconazole—Urticaria—Doxorubicin—testicular cancer	0.00211	0.00211	CcSEcCtD
Terconazole—Abdominal pain—Doxorubicin—testicular cancer	0.0021	0.0021	CcSEcCtD
Terconazole—Body temperature increased—Doxorubicin—testicular cancer	0.0021	0.0021	CcSEcCtD
Terconazole—Asthenia—Epirubicin—testicular cancer	0.00206	0.00206	CcSEcCtD
Terconazole—Pruritus—Epirubicin—testicular cancer	0.00203	0.00203	CcSEcCtD
Terconazole—Dizziness—Methotrexate—testicular cancer	0.00202	0.00202	CcSEcCtD
Terconazole—Hypersensitivity—Doxorubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
Terconazole—Vomiting—Methotrexate—testicular cancer	0.00195	0.00195	CcSEcCtD
Terconazole—Rash—Methotrexate—testicular cancer	0.00193	0.00193	CcSEcCtD
Terconazole—Dermatitis—Methotrexate—testicular cancer	0.00193	0.00193	CcSEcCtD
Terconazole—Headache—Methotrexate—testicular cancer	0.00192	0.00192	CcSEcCtD
Terconazole—Asthenia—Doxorubicin—testicular cancer	0.0019	0.0019	CcSEcCtD
Terconazole—Dizziness—Epirubicin—testicular cancer	0.00189	0.00189	CcSEcCtD
Terconazole—Pruritus—Doxorubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Terconazole—Vomiting—Epirubicin—testicular cancer	0.00182	0.00182	CcSEcCtD
Terconazole—Nausea—Methotrexate—testicular cancer	0.00182	0.00182	CcSEcCtD
Terconazole—Rash—Epirubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Terconazole—Dermatitis—Epirubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Terconazole—Headache—Epirubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Terconazole—Dizziness—Doxorubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Terconazole—Nausea—Epirubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Terconazole—Vomiting—Doxorubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Terconazole—Rash—Doxorubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Terconazole—Dermatitis—Doxorubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Terconazole—Headache—Doxorubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Terconazole—Nausea—Doxorubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
